Study of carrier of circulating microRNAs in pancreatic cancer
10.3760/cma.j.issn.1674-1935.2014.06.002
- VernacularTitle:胰腺癌循环微小核糖核酸载体的研究
- Author:
Hui FENG
;
Yalei WANG
;
Xi CHEN
;
Chenyu ZHANG
;
Yaozong YUAN
;
Weiyan YAO
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
MicroRNAs;
Microvesicle
- From:
Chinese Journal of Pancreatology
2014;14(6):366-369
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the circulating microRNAs carrier in pancreatic cancer.Methods Pancreatic cancer cell lines SW1990 and BxPC3 were routinely cultured and serum of 6 patients with pancreatic cancer and 6 healthy subjects (control group) were collected.Serum and pancreatic cancer cell line supernatant microvesicles (MV) were obtained by gradient centrifugation.The expression of Ago2,CD63 was detected by Western blotting,the expression of microRNA in microvesicle section and microvesicle-free section in serum was detected by using quantitative PCR method.Results The supernatant MV of pancreatic cancer cell lines expressed Ago2,CD63 protein,and these MV carried different microRNAs in different cell lines.In the serum of pancreatic cancer and control group,miR-20a,miR-21,miR-24,miR-25,miR-191,miR-483-5p were detected,but the quantity was relatively higher in MV section,and the expression of microRNAs in pancreatic cancer's MV was inconsistent with that of control group.The expression of miR-20a,miR-24,miR-191 in pancreatic cancer group was (2.93 ± 0.29),(2.73 ± 0.46),(2.39 ± 0.51) times as much as those in control group,and the difference between the two groups was statistically significant (F =75.97,25.80,12.94,P ＜ 0.05 or ＜ 0.01).Conclusions The main circulating microRNAs carrier in pancreatic cancer is microvesicle.
